20
Informaciones
Psiquiátricas
2016 - n.º 224
Jordi Serra-Mestres
14. Busse A, Hensel A, Ghüne U, Angerme-
yer MC, Riedel-Heller SG. Mild cognitive
impairment: long-term course of four
clinical subtypes. Neurology 2006; 67:
2176-2185.
15. Cooper C, Li R, Lyketsos C, Livingston
G. Treatment for mild cognitive impair-
ment: a systematic review. Br J Psychia-
try 2013; 203: 255-264.
16. Stomrud E, Hansson O, Minthon L, Blen-
now K, Rosén I, Londos E. Slowing of
EEG correlates with CSG biomarkers and
reduced cognitive speed in elderly with
normal cognition over 4 years. Neuro-
biol Aging 2010; 31: 215-223.
17. Visser PJ, Knopman DS. Amyloid ima-
ging in the prediction of Alzheimer-type
dementia in subjects with amnestic MCI.
Neurology 2009; 73: 744-745.
18. Van der Flier WM, van Buchem MA, We-
verling-Rijnsburger AW, et al. Memory
complaints in patients with normal
cognition are associated with smaller
hippocampal volumes. J Neurol 2004;
251: 671-675.
19. Aggarwal NT, Wilson RS, Beck TL, Bie-
nieas JL, Berry-Kravis E, Bennett DA.
The apolipoprotein E epsilon4 allele and
incident Alzheimer’s disease in persons
with mild cognitive impairment. Neuro-
case 2005; 11: 3-7.
20. Reisberg B, Prichep L, Mosconi L, et al.
The pre-mild cognitive impairment, sub-
jective cognitive impairment stage of
Alzheimer’s disease. Alzheimers Dement
2008; 4: S98-S108.
21. Smailagic N, Vacante M, Hyde C, et al.
18F-FDG PET for the early diagnosis of
Alzheimer’s disease dementia and other
dementias in people with mild cognitive
impairment. Cochrane Library 2015; DOI
10.1002/14651858.CD10632.pub2.
22. Stone J. Functional symptoms in neuro-
logy. Neurol Pract 2009; 9: 179-189.
23. Staniloiu A, Markowitsch HJ. Dissociati-
ve amnesia. Lancet Psychiatry 2014; 1:
226-241.
24. Foote B, Smolin Y, Neft DI, Lipschitz D.
Disssociative disorders and suicidality in
psychiatric outpatients. J Nerv Ment Dis
2008; 196: 29-36.
25. Dell PF. Three dimensions of dissociative
amnesia. J Trauma Dissoc 2013; 14: 25-
39.
